Last $1.89 USD
Change Today -0.01 / -0.53%
Volume 40.1K
VRML On Other Exchanges
As of 2:38 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce Allan Huebner

Independent Director and Member of Compensation Committee, Biocept, Inc.
AgeTotal Calculated CompensationThis person is connected to 37 board members in 2 different organizations across 8 different industries.

See Board Relationships


Mr. Bruce Allan Huebner was the President of Clinical Micro Sensors, Inc. Mr. Huebner served as the President and Chief Operating Officer of Nanogen, Inc. at SynX Pharma Inc. from December 2002 to June 2, 2004 and from December 2000 to June 2, 2004 respectively. He was Consultant of Nanogen, Inc. from September 2002 to June 2, 2004. He has an active consulting business with a focus on cancer diagnostics and personalized medicine. He has over 35 years of experience in ...

Read Full Background

Corporate Headquarters*

Building III
Austin, Texas 78738

United States

Phone: 512-519-0400
Fax: 512-439-6980

Board Members Memberships*

Former Executive Director and President of Molecular Diagnostics Division
Former Chief Executive Officer, President and Director
Former Chairman
Former Independent Director, Chairman of Audit Committee and Member of Compensation Committee
Independent Director and Member of Compensation Committee


University of Wisconsin, LaCrosse

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Calculated Compensation$80,814
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRML:US $1.89 USD -0.01


Jay T. Flatley Chief Executive Officer and Director
Illumina Inc.
Gajus V. Worthington Co-Founder, Chief Executive Officer, President and Director
Fluidigm Corporation
Alexandre Mérieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
Joji Nakayama Chief Executive Officer, President and Representative Director
Daiichi Sankyo Company, Limited
Steven C. Quay M.D., Ph.D., FCAPChairman, Chief Executive Officer, President and Treasurer
Atossa Genetics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERMILLION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at